Regarding the potential relevance of RANK/RANKL in hereditary BC and in the immunopathogenesis of experimental tumours and malignant melanoma patients, we hypothesized a differential regulation of this pathway in OC. This evidence concerns the gene TNFRSF11A and neoplasm.